Search for: "In re Nexium Antitrust Litigation"
Results 1 - 20
of 23
Sorted by Relevance
|
Sort by Date
8 Dec 2016, 2:00 am
€ 160 The post USA: In re Nexium (Esomeprazole) Antitrust Litigation, United States Court of Appeals, First Circuit, Nos. 15-2005, 21 November 2016 appeared first on Kluwer Patent Blog. [read post]
28 May 2014, 10:31 am
In re AndroGel Antitrust Litigation (No. [read post]
11 Nov 2015, 3:56 pm
I have found one trial court case, In re Nexium Antitrust Litigation (D. [read post]
29 Aug 2012, 10:09 pm
” NEXIUM. [read post]
16 Jun 2010, 3:50 pm
But don’t say this directly to the competitor; remind it indirectly, otherwise you have an antitrust problem. [read post]
17 Oct 2008, 1:32 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride… [read post]
27 Jul 2017, 12:45 pm
” In re Nexium Antitrust Litig., 777 F.3d 9, 20 (1st Cir. 2015). [read post]
15 May 2015, 4:43 am
Court of Appeals for the First district held in In re Nexium Antitrust Litigation, 2015 WL 265548 (1st Cir., Jan. 21, 2015), that so long as “it will be possible to establish a mechanism for distinguishing the injured from the uninjured class members,” particularly where a proposed class includes a “de minimis” number of uninjured parties, a class may still be certified pursuant to Federal Rule of Civil Procedure 23(b)(3). [read post]
22 Oct 2018, 5:56 am
(In re Asacol Antitrust Litig.), No. 18-1065, 2018 U.S. [read post]
6 Feb 2015, 9:18 am
” In re Nexium Antitrust Litigation, 2015 U.S. [read post]
6 Feb 2015, 9:18 am
” In re Nexium Antitrust Litigation, 2015 U.S. [read post]
27 Feb 2015, 4:58 am
The decision of the First Circuit in In re Nexium Antitrust Litig., Nos. 14-1521, 14-1522, 2015 U.S. [read post]
12 Feb 2015, 3:15 pm
Foodservice Inc. ( In re U.S. [read post]
27 Sep 2019, 6:00 am
They’re constantly trading off options to shape future rents. [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and de-branding of… [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
11 Jul 2008, 4:30 am
Part I – Spicy IP), India: Discussion of grant of Indian patents to Cipla for Fosamax derivative and Nexium derivative: (Spicy IP), India: Draft National Biotechnology Regulatory Authority Bill: (Spicy IP), Ivory Coast: Ivorians increasingly choose fake medicines on price: (Afro-IP), Mexico: New Mexican medicaments approvals regime: an early report: (IP tango), UK: Leave to appeal refused in trade mark infringement proceedings between Eli Lilly and 8PM Chemist concerning the… [read post]
5 Sep 2008, 11:01 pm
(IP finance), Microsoft and Nikon sign patent cross-licensing agreement covering consumer electronics: (Managing Intellectual Property), World day against software patents: (Spicy IP), (IPKat), Patents.com – PatentMonkey redux: (The Patent Librarian’s Notebook), Women and patents: it is not working at the moment: (IAM) Experts discuss the role of IP in environmental technology transfer: (Intellectual Propery Watch), WIPO’s 2008 World Patent Report: (The Patent… [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is… [read post]
22 Feb 2008, 6:00 pm
), (Washington State Patent Law Blog), (The IP Factor), (IPBiz), (IP Spotlight), (IP Law360), (Innovationpartners), (IPBiz),US FTC files complaint against Cephalon alleging the company paid four generic drug manufacturers (Ranbaxy, Teva, Mylan and Barr) to delay entry as part of litigation settlements: (IP Law360), (IP Law360), (Spicy IP),GlobalGlobal - GeneralWhat is IP value all about? [read post]
